Untranslated

More Language

86-21-64556180

cpd-service@caerulumpharma.com

Ikhaya
Mayelana NATHI
Imikhiqizo
Izixazululo
Izinsiza
- Ibhayisikobho yezimanga
- Igalari yezithombe
Imibuzo Evame Ukubuzwa
Xhumana nathi

Ikhaya
Imikhiqizo
Ama-molecule e-bioactive
I-Antineoplastic
I-BRAF

Izigaba Zemikhiqizo

I-Antineoplastic
- I-ACC
- I-Adenosine A2A
- I-ALK
- I-Androgen receptor inhibitor
- I-Apoptosis stimulant
- I-ATR
- I-AXL
- I-BCl2-BH4
- Bcr-Abl
- I-BRAF
- I-BTK
- I-CDK
- Chk1
- I-CYP17
- I-alkylating ejenti ye-DNA
- EED
- I-EGFR
- EP4
- ER
- I-FAK
- I-FGFR
- I-FLT3
- Glutaminase
- NGIYAVUMA
- I-IRA
- KIT
- I-LXR
- I-MDM2
- MEK
- MET
- Nrf2
- I-P90RSK
- P97
- I-PAKS
- I-PARP
- I-PI3K
- I-Plk-1
- I-SMYD2
- I-SRC
- I-TOPK
- I-VEGFR
Izidakamizwa ze-Hypoglycemic
Abanye
- 5HT
- AMPK
- I-Arginase
- I-CRF-1
- CXCR2
- FLAP
- I-FXR
- GABA
- Gi activator
- GR
- UJAK
- LABA
- ama-machRs
- I-NF-kB
- I-NRTI
- PPAR
- I-RIP1
- I-S1PR
- I-SGC
- I-SYK
- α2δ-1
- ibb3
- I-β2-adrenoceptor
- σ1

I-BRAF

IKATI #

Igama Lomkhiqizo

Incazelo

...

Xhumana nathi

No. 401, 4th Floor, Building 6, Quwu Road 589, Minhang District, 200241 Shanghai, China
86-21-64556180
E-China:
sales-cpd@caerulumpharma.com
Okwamazwe ngamazwe:
cpd-service@caerulumpharma.com

Uphenyo

Ngemibuzo ngemikhiqizo yethu, sicela usishiyele i-imeyili futhi sizokuthinta phakathi namahora angu-24.Uphenyo

Izindaba zakamuva

I-AstraZeneca ithola ukuthuthukiswa kokulawulwa kwezidakamizwa ze-oncology

I-AstraZeneca ithola amandla okulawula...

I-AstraZeneca ithole ukuthuthukiswa okuphindwe kabili kuphothifoliyo yayo ye-oncology ngoLwesibili, ngemuva kokuthi abalawuli baseMelika nabaseYurophu bemukele ukuthunyelwa kwemithi yayo, isinyathelo sokuqala sokuzuza ukugunyazwa kwale mithi. ...

Amathrendi ayi-7 aphezulu Ocwaningweni Lwezemithi Ngo-2018

Amathrendi ayi-7 aphezulu Ocwaningweni Lwezemithi I...

Njengoba zingaphansi kwengcindezi ehlala ikhuphuka yokuncintisana endaweni yezomnotho nezobuchwepheshe eyinselele, izinkampani zemithi ne-biotech kumele ziqhubeke zisungula izinhlelo zazo ze-R&D ukuze zihlale ziphambili ...

I-ARS-1620: I-inhibitor entsha ethembisayo ye-KRAS-mutant cancers

I-ARS-1620: I-inhibitor entsha ethembisayo ye-K...

Ngokocwaningo olushicilelwe ku-Cell, abacwaningi benze inhibitor ethile ye-KRASG12C ebizwa nge-ARS-1602 eyenza ukuhlehla kwesimila kumagundane. "Lolu cwaningo lunikeza ubufakazi obubonakalayo bokuthi i-KRAS eguquguqukayo ingaba ...

I-AstraZeneca ithola ukuthuthukiswa kokulawulwa kwezidakamizwa ze-oncology

I-AstraZeneca ithola amandla okulawula...

I-AstraZeneca ithole ukuthuthukiswa okuphindwe kabili kuphothifoliyo yayo ye-oncology ngoLwesibili, ngemuva kokuthi abalawuli baseMelika nabaseYurophu bemukele ukuthunyelwa kwemithi yayo, isinyathelo sokuqala sokuzuza ukugunyazwa kwale mithi. ...

Amathrendi ayi-7 aphezulu Ocwaningweni Lwezemithi Ngo-2018

Amathrendi ayi-7 aphezulu Ocwaningweni Lwezemithi I...

Njengoba zingaphansi kwengcindezi ehlala ikhuphuka yokuncintisana endaweni yezomnotho nezobuchwepheshe eyinselele, izinkampani zemithi ne-biotech kumele ziqhubeke zisungula izinhlelo zazo ze-R&D ukuze zihlale ziphambili ...

prev

next

© Copyright - 2015-2022 : Wonke Amalungelo Agodliwe.

Imibuzo Evame Ukubuzwa
Ibhayisikobho yezimanga
Xhumana nathi

Thumela I-imeyili

Ikhodi ye-QR

Ingxoxo ye-WhatsApp Online!

TOP

Previous Maximize